T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
about
Cytomegalovirus-induced immunopathology and its clinical consequencesThe Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMVType 1 responses of human Vγ9Vδ2 T cells to influenza A viruses.A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograftThe aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice.Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipientsFrequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxisHuman cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infectionCytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naïve recipientsAcceleration of allograft failure by cytomegalovirusLatent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients.Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung TransplantationVascular dysfunction in young, mid-aged and aged mice with latent cytomegalovirus infections.Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection.Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cellsProtective CD8+ T-cell responses to cytomegalovirus driven by rAAV/GFP/IE1 loading of dendritic cellsAssociation of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients.Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing.Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies.Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy.Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update.CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation.Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies.Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.Simultaneous Monitoring of Cytomegalovirus-Specific Antibody and T-cell levels in Seropositive Heart Transplant Recipients
P2860
Q21195897-F368646A-24B8-428B-85A5-FBB722669AA8Q26768481-4DD7E45D-5F21-4B76-BE66-B74E37E6B18DQ30404808-7186BC4D-2E3E-44B1-B1A5-2560CE5785CFQ34105900-CC7CF01B-8A65-4B98-87CF-EDD47EF3B8B5Q35102332-FC4277DB-5DBA-43C7-8721-8316287A6E0CQ35544428-8C6A4BEC-4580-4670-A490-818676C683B0Q35914030-D65A7763-D18E-489F-B181-8BDD1F5B8B89Q36023008-8150D8B5-5FA9-4B0A-A7C9-3021DC37F5E6Q36266751-DBDAB996-60E6-47F4-B260-9773356E5B42Q36433529-09C25247-2422-4917-8057-C2BE90B232CDQ36516318-B5CFBA3E-DA9B-45EA-A79D-2D5B8A5CB2DBQ36516505-E66A76CA-0F58-47E2-B5FC-C5CB67C37967Q36528054-A238F0CD-46B0-4660-BF69-A583954187B4Q36612933-E5691006-EB91-4281-9508-C2DF4EE98B8BQ36868786-6549A65A-407D-404C-98A4-F38657EA9B49Q36944377-35421C93-2971-4490-B193-DF9777813055Q37029903-6CE17175-8093-412A-B95E-25EC2F3866C0Q37220021-0B4E26FF-D769-46F5-91D1-7774531B230AQ37778827-C7956B79-92AD-4CDB-B111-DD531BC0198EQ37965695-A689AAF3-8571-4FE2-A26F-D88B15BC16C3Q38875887-4F5E31FA-B605-4A8B-87AF-04C327300545Q40973756-29575CCF-C67D-446F-80DE-A5CB09B9888AQ42366690-A67CB3E2-0A89-4F3F-A538-DD0A3F1C1ED7Q52653110-A27BDA1E-0EC0-4A3B-8B38-170FC88FE2D9Q57568998-5065E55E-60E2-4990-800F-3E334B3C8C29
P2860
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
T-cell immunity to subclinical ...... ces cardiac allograft disease.
@en
T-cell immunity to subclinical ...... ces cardiac allograft disease.
@nl
type
label
T-cell immunity to subclinical ...... ces cardiac allograft disease.
@en
T-cell immunity to subclinical ...... ces cardiac allograft disease.
@nl
prefLabel
T-cell immunity to subclinical ...... ces cardiac allograft disease.
@en
T-cell immunity to subclinical ...... ces cardiac allograft disease.
@nl
P2093
P1433
P1476
T-cell immunity to subclinical ...... ces cardiac allograft disease.
@en
P2093
Clifford Chin
David B Lewis
Edward S Mocarski
Hannah A Valantine
Helen Luikart
Kira Y Dionis
Lanxiang Liu
Luciano Potena
Pamela Stepick-Biek
Tyson H Holmes
P304
P356
10.1161/CIRCULATIONAHA.105.607549
P407
P577
2006-10-02T00:00:00Z